文献速递眼底病与葡萄膜炎青光眼白内障与屈光手术

单一执业机构行政理赔与电子健康登记数据用于眼健康监测的有效性

Validity of Administrative Claims and Electronic Health Registry Data From a Single Practice for Eye Health Surveillance.
PubMed 文献 · JAMA Ophthalmol · 2023-01-01

这项横断面研究在华盛顿大学附属眼科或验光诊所2018年5月至2020年4月的数据中,比较理赔与电子健康记录(EHR)诊断编码同回顾性病历审查的一致性。669名参与者中,糖尿病视网膜病变、青光眼、年龄相关性黄斑变性和白内障的编码识别准确(AUC 0.82–0.97),但屈光与调节障碍、盲与低视力、眼眶与外部疾病的AUC低于0.7。

要点

  • 理赔与EHR编码对糖尿病视网膜病变、青光眼、年龄相关性黄斑变性和白内障的识别准确。
  • 屈光与调节障碍、盲与低视力、眼眶与外部疾病的编码效度低,AUC均低于0.7。

核心结论

  • 在当前和近期眼科患者中,基于理赔和EHR诊断编码识别主要威胁视力的眼病是准确的。
  • 视力丧失、屈光不正及其他定义宽泛或较低风险疾病类别的诊断编码识别准确性较低。

研究设计与样本

  • 横断面研究,比较EHR和理赔记录中的诊断编码与临床病历回顾,数据来自华盛顿大学附属眼科或验光诊所2018年5月至2020年4月。
  • 纳入669名16岁及以上、过去2年内接受过眼科检查的患者,对确诊主要眼病和视力丧失者进行过采样。

主要发现

  • 糖尿病视网膜病变:理赔AUC 0.94(95%CI 0.91-0.98),EHR AUC 0.97(95%CI 0.95-0.99)。
  • 青光眼:理赔AUC 0.90(95%CI 0.88-0.93),EHR AUC 0.93(95%CI 0.90-0.95)。
  • 年龄相关性黄斑变性:理赔AUC 0.87(95%CI 0.83-0.92),EHR AUC 0.96(95%CI 0.94-0.98)。
  • 白内障:理赔AUC 0.82(95%CI 0.79-0.86),EHR AUC 0.91(95%CI 0.89-0.93)。
  • 屈光与调节障碍:理赔AUC 0.54(95%CI 0.49-0.60),EHR AUC 0.61(95%CI 0.56-0.67);盲与低视力:理赔AUC 0.56(95%CI 0.53-0.58),EHR AUC 0.57(95%CI 0.54-0.59);眼眶与外部疾病:理赔AUC 0.63(95%CI 0.57-0.69),EHR AUC 0.65(95%CI 0.59-0.70)。

关键数值与推荐

  • 使用美国疾病控制与预防中心视力与眼健康监测系统(VEHSS)的诊断病例定义,将患者归入视力和眼健康疾病类别。
  • 以回顾性病历审查中的临床评估和治疗计划为参考标准,用受试者工作特征曲线下面积(AUC)衡量准确性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Diagnostic information from administrative claims and electronic health record (EHR) data may serve as an important resource for surveillance of vision and eye health, but the accuracy and validity of these sources are unknown. OBJECTIVE: To estimate the accuracy of diagnosis codes in administrative claims and EHRs compared to retrospective medical record review. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study compared the presence and prevalence of eye disorders based on diagnostic codes in EHR and claims records vs clinical medical record review at University of Washington-affiliated ophthalmology or optometry clinics from May 2018 to April 2020. Patients 16 years and older with an eye examination in the previous 2 years were included, oversampled for diagnosed major eye diseases and visual acuity loss. EXPOSURES: Patients were assigned to vision and eye health condition categories based on diagnosis codes present in their billing claims history and EHR using the diagnostic case definitions of the US Centers for Disease Control and Prevention Vision and Eye Health Surveillance System (VEHSS) as well as clinical assessment based on retrospective medical record review. MAIN OUTCOME AND MEASURES: Accuracy was measured as area under the receiver operating characteristic curve (AUC) of claims and EHR-based diagnostic coding vs retrospective review of clinical assessments and treatment plans. RESULTS: Among 669 participants (mean [range] age, 66.1 [16-99] years; 357 [53.4%] female), identification of diseases in billing claims and EHR data using VEHSS case definitions was accurate for diabetic retinopathy (claims AUC, 0.94; 95% CI, 0.91-0.98; EHR AUC, 0.97; 95% CI, 0.95-0.99), glaucoma (claims AUC, 0.90; 95% CI, 0.88-0.93; EHR AUC, 0.93; 95% CI, 0.90-0.95), age-related macular degeneration (claims AUC, 0.87; 95% CI, 0.83-0.92; EHR AUC, 0.96; 95% CI, 0.94-0.98), and cataracts (claims AUC, 0.82; 95% CI, 0.79-0.86; EHR AUC, 0.91; 95% CI, 0.89-0.93). However, several condition categories showed low validity with AUCs below 0.7, including diagnosed disorders of refraction and accommodation (claims AUC, 0.54; 95% CI, 0.49-0.60; EHR AUC, 0.61; 95% CI, 0.56-0.67), diagnosed blindness and low vision (claims AUC, 0.56; 95% CI, 0.53-0.58; EHR AUC, 0.57; 95% CI, 0.54-0.59), and orbital and external diseases (claims AUC, 0.63; 95% CI, 0.57-0.69; EHR AUC, 0.65; 95% CI, 0.59-0.70). CONCLUSION AND RELEVANCE: In this cross-sectional study of current and recent ophthalmology patients with high rates of eye disorders and vision loss, identification of major vision-threatening eye disorders based on diagnosis codes in claims and EHR records was accurate. However, vision loss, refractive error, and other broadly defined or lower-risk disorder categories were less accurately identified by diagnosis codes in claims and EHR data.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wittenborn JS, Lee AY, Lundeen EA, et al. Validity of Administrative Claims and Electronic Health Registry Data From a Single Practice for Eye Health Surveillance. JAMA Ophthalmol. 2023. PMID: 37140901. doi:10.1001/jamaophthalmol.2023.1263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。